{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:02:39Z","timestamp":1791115359145,"version":"4.1.0"},"reference-count":48,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2006,10,1]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p> Retrospective studies suggest cytogenetic abnormalities detected by interphase fluorescent in situ hybridization (FISH) can identify patients with chronic lymphocytic leukemia (CLL) who will experience a more aggressive disease course. Other studies suggest that patients may acquire chromosome abnormalities during the course of their disease. There are minimal prospective data on the clinical utility of the widely used hierarchical FISH prognostic categories in patients with newly diagnosed early-stage CLL or the frequency of clonal evolution as determined by interphase FISH. <\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p> Between 1994 and 2002, we enrolled 159 patients with previously untreated CLL (83% Rai stage 0\/I) on a prospective trial evaluating clonal evolution by FISH. Patients provided baseline and follow-up specimens for FISH testing during 2 to 12 years. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> Chromosomal abnormalities detected by FISH at study entry predicted overall survival. Eighteen patients experienced clonal evolution during follow-up. The rate of clonal evolution increased with duration of follow-up with only one occurrence in the first 2 years (n = 71; 1.4%) but 17 occurrences (n = 63; 27%) among patients tested after 5+ years. Clonal evolution occurred among 10% of ZAP-70\u2013negative and 42% of ZAP-70\u2013positive patients at 5+ years (P = .008). <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> This clinical trial confirms prospectively that cytogenetic abnormalities detected by FISH can predict overall survival for CLL patients at the time of diagnosis, but also suggests that many patients acquire new abnormalities during the course of their disease. Patients with higher ZAP-70 expression may be more likely to experience such clonal evolution. These findings have important implications for both clinical management and trials of early treatment for patients with high-risk, early-stage CLL. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.2006.06.9492","type":"journal-article","created":{"date-parts":[[2006,9,28]],"date-time":"2006-09-28T22:40:20Z","timestamp":1159483220000},"page":"4634-4641","source":"Crossref","is-referenced-by-count":197,"title":["Prospective Evaluation of Clonal Evolution During Long-Term Follow-Up of Patients With Untreated Early-Stage Chronic Lymphocytic Leukemia"],"prefix":"10.1200","volume":"24","author":[{"given":"Tait D.","family":"Shanafelt","sequence":"first","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Witzig","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie R.","family":"Fink","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Jenkins","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"Paternoster","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Smoley","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly J.","family":"Stockero","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Nast","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather C.","family":"Flynn","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee C.","family":"Tschumper","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Geyer","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive S.","family":"Zent","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim G.","family":"Call","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane F.","family":"Jelinek","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E.","family":"Kay","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon W.","family":"Dewald","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Department Pathology, Division of Cytogenetics, Department of Immunology, Division of Biostatistics, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)62215-0"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.bloodjournal462219"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V56.4.640.bloodjournal564640"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Robert KH, Gahrton G, Friberg K, et al: Extra chromosome 12 and prognosis in chronic lymphocytic leukaemia. Scand J Haematol 28:163,1982-168,","DOI":"10.1111\/j.1600-0609.1982.tb00509.x"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199009133231105"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400819"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(97)00095-7"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03719.x"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04265.x"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.6.1580.bloodjournal8561580"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.4.1177.h81602001177_1177_1184"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1048.2001.3205.x"},{"key":"R17","unstructured":"Fegan C, Robinson H, Thompson P, et al: Karyotypic evolution in CLL: Identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. Leukemia 9:2003,1995-2008,"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199811)59:3<223::AID-AJH7>3.0.CO;2-Y"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870030104"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Nowell PC, Moreau L, Gowney P, et al: Karyotypic stability in chronic B-cell Leukemia. Cancer Genet Cytogenet 33:155,1988-160,","DOI":"10.1016\/0165-4608(88)90025-8"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.12.3835"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03149.x"},{"key":"R24","unstructured":"Jelinek DF, Tschumper RC, Stolovitzky GA, et al: Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Mol Cancer Res 1:346,2003-361,"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.1077"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Juliusson G, Gahrton G, Oscier G, et al: Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia: Second IWCCLL compilation of data on 662 patients. Leuk Lymphoma 21,1991-25,  (suppl)","DOI":"10.3109\/10428199109103374"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01259.x"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.10.2702.2702"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402537"},{"key":"R30","unstructured":"Bergmann M, Eichorst B, R B, et al: Elevated thymidine kinase and short lymphocyte doubling time in combination with unfavourable cytogenetics or unmutated IgVH status are strong predictors for high individual risk for rapid disease progression in patients with B-CLL in Binet stage A: An interim report from the CLL1 Protocol of the German CLL Study Group (GCLLSG). Blood 102,2003,  (abstr 2464)"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2004.1.163"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Oscier DG, Richards S, Orchard J, et al: Prognostic factors in the UK LRF CLL4 Trial. Blood 106,2005,  (abstr 2099)","DOI":"10.1182\/blood.V106.11.2099.2099"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1848"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1840"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.1023"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1801"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa023143"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Orchard JA, Best OG, Ibbotson RE, et al: ZAP-70 by flow cytometry: Comparison of methodologies, and with IgVH mutation and ZAP-70 methylation status. Blood 106,2005,  (abstr 1181)","DOI":"10.1182\/blood.V106.11.1181.1181"},{"key":"R39","doi-asserted-by":"crossref","unstructured":"Durig J, Nuckel H, Cremer M, et al: ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 17:2422,2003-2434,","DOI":"10.1038\/sj.leu.2403147"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040857"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.7184"},{"key":"R42","unstructured":"Cuneo A, Bigoni R, Rigolin GM, et al: Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders: Clinico-biological significance. Haematologica 87:44,2002-51,"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3236"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.11.3452.3452"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.1021"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2281"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05548.x"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3729"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2006.06.9492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:23:50Z","timestamp":1653513830000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2006.06.9492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":48,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2006,10,1]]}},"alternative-id":["10.1200\/JCO.2006.06.9492"],"URL":"https:\/\/doi.org\/10.1200\/jco.2006.06.9492","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,1]]}}}